Skip to main content
Clinical Trials/DRKS00003155
DRKS00003155Active, not recruitingNot Applicable

The relevance of serum microRNAs in the diagnosis of prostate cancer

niversitätsklinikum BonnKlinik und Poliklinik für Urologie und Kinderurologie0 sites43 target enrollmentStarted: June 22, 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
43

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
40 Years to one (—)
Sex
Male

Inclusion Criteria

  • indication of prostate biopsy according the S3-guideline prostate cancer, suspicion of prostate cancer (e.g. PSA elevation, abnormal digital-rectal examination, abnormal transrectal sonography)
  • - age > 40 years
  • - sex: male

Exclusion Criteria

  • history of secondary malignancy within the last 5 years

Investigators

Sponsor
niversitätsklinikum BonnKlinik und Poliklinik für Urologie und Kinderurologie

Similar Trials

The relevance of serum microRNAs in the... | Clinical Trial